A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR.
暂无分享,去创建一个
M. Bowman | J. Noel | J. Hogenesch | R. Evans | M. Downes | M. Verdecia | A. Roecker | R. Hughes | Heidi R. Kast-Woelbern | J. Ferrer | A. Anisfeld | P. Edwards | J. Rosenfeld | J. G. Alvarez | K. Nicolaou | A. J. Roecker | Mark A. Verdecia | R. Evans | K. C. Nicolaou | K. Nicolaou
[1] R. Evans,et al. The steroid and thyroid hormone receptor superfamily. , 1988, Science.
[2] J. Zou,et al. Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.
[3] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[4] Jasmine Chen,et al. Identification of a nuclear receptor that is activated by farnesol metabolites , 1995, Cell.
[5] S. Doublié. [29] Preparation of selenomethionyl proteins for phase determination. , 1997, Methods in enzymology.
[6] Z. Otwinowski,et al. [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[7] W. Sabbagh,et al. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. , 1998, Genes & development.
[8] R. Evans,et al. Orphan nuclear receptors--new ligands and new possibilities. , 1998, Genes & development.
[9] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[10] Thomas C. Terwilliger,et al. Automated MAD and MIR structure solution , 1999, Acta crystallographica. Section D, Biological crystallography.
[11] M. Makishima,et al. Identification of a nuclear receptor for bile acids. , 1999, Science.
[12] Jasmine Chen,et al. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. , 1999, Molecular cell.
[13] T. Willson,et al. Identification of a Bile Acid-responsive Element in the Human Ileal Bile Acid-binding Protein Gene , 1999, The Journal of Biological Chemistry.
[14] J. Lehmann,et al. Bile acids: natural ligands for an orphan nuclear receptor. , 1999, Science.
[15] Thomas C. Terwilliger,et al. Electronic Reprint Biological Crystallography Maximum-likelihood Density Modification , 2022 .
[16] K. Nicolaou,et al. Natural Product-like Combinatorial Libraries Based on Privileged Structures. 2. Construction of a 10 000-Membered Benzopyran Library by Directed Split-and-Pool Chemistry Using NanoKans and Optical Encoding , 2000 .
[17] Helen J. Mitchell,et al. Natural Product-like Combinatorial Libraries Based on Privileged Structures. 1. General Principles and Solid-Phase Synthesis of Benzopyrans , 2000 .
[18] T. A. Kerr,et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. , 2000, Molecular cell.
[19] D. Moras,et al. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. , 2000, Molecular cell.
[20] Richard A. Heyman,et al. Orphan Nuclear Receptors , 2000 .
[21] L. Moore,et al. Identification of a chemical tool for the orphan nuclear receptor FXR. , 2000, Journal of medicinal chemistry.
[22] Masahiro Tohkin,et al. Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis , 2000, Cell.
[23] R. Dixon,et al. Dissection of malonyl-coenzyme A decarboxylation from polyketide formation in the reaction mechanism of a plant polyketide synthase. , 2000, Biochemistry.
[24] L. Moore,et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. , 2000, Molecular cell.
[25] D. Moore,et al. The Farnesoid X-activated Receptor Mediates Bile Acid Activation of Phospholipid Transfer Protein Gene Expression* , 2000, The Journal of Biological Chemistry.
[26] A. Roecker,et al. Natural Product-like Combinatorial Libraries Based on Privileged Structures. 3. The “Libraries from Libraries” Principle for Diversity Enhancement of Benzopyran Libraries , 2000 .
[27] P. Chambon,et al. Crystal structure of the human RXRα ligand‐binding domain bound to its natural ligand: 9‐cis retinoic acid , 2000 .
[28] R. Evans,et al. “Don't Know Much Bile-ology” , 2000, Cell.
[29] P. Edwards,et al. Identification of the DNA Binding Specificity and Potential Target Genes for the Farnesoid X-activated Receptor* , 2000, The Journal of Biological Chemistry.
[30] A. Steinmetz,et al. X‐ray structure of the orphan nuclear receptor RORβ ligand‐binding domain in the active conformation , 2001, The EMBO journal.
[31] L. Moore,et al. Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[32] L. Moore,et al. The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity , 2001, Science.
[33] T. Willson,et al. 6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. , 2002, Journal of medicinal chemistry.
[34] J. Chiang,et al. Bile acid regulation of gene expression: roles of nuclear hormone receptors. , 2002, Endocrine reviews.
[35] D. Russell,et al. Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. , 2002, Developmental cell.
[36] M. Karin,et al. Redundant pathways for negative feedback regulation of bile acid production. , 2002, Developmental cell.
[37] Paul T Tarr,et al. Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor* , 2002, The Journal of Biological Chemistry.
[38] A. Anisfeld,et al. BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. , 2002, Journal of lipid research.
[39] D. Mangelsdorf,et al. A Natural Product That Lowers Cholesterol As an Antagonist Ligand for FXR , 2002, Science.
[40] R. Evans,et al. Discovery and optimization of non-steroidal FXR agonists from natural product-like libraries. , 2003, Organic & biomolecular chemistry.